Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery

ClinicalTrials.gov ID: NCT05528172

Public ClinicalTrials.gov record NCT05528172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Treatment and 14-week Extension, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery

Study identification

NCT ID
NCT05528172
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kowa Research Institute, Inc.
Industry
Enrollment
331 participants

Conditions and interventions

Interventions

  • Ripasudil Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 3, 2022
Primary completion
Jun 21, 2023
Completion
Jun 21, 2023
Last update posted
May 23, 2024

2022 – 2023

United States locations

U.S. sites
44
U.S. states
19
U.S. cities
40
Facility City State ZIP Site status
Cornea and Cataract Consultants of Arizona Phoenix Arizona 85032
Schwartz Laser Eye Center Scottsdale Arizona 85260
Inland Eye Specialists Hemet California 92545
United Medical Research Institute Inglewood California 90301
Alvarado Eye Associates La Mesa California 91942
SoCal Eye Physicians and Associates Long Beach California 90805
Visionary Research Institute Newport Beach California 92663
Pendleton Eye Center Oceanside California 92056
North Bay Eye Associates Petaluma California 94954
Martel Eye Medical Group Rancho Cordova California 95670
Premiere Practice Management, LLC Torrance California 90505
Wolstan and Goldberg Eye Associates Torrance California 90505
Icon Eye Care Grand Junction Colorado 81501
Eye Associates of Fort Myers Fort Myers Florida 33901
Levenson Eye Associates Jacksonville Florida 32204
International Research Center Tampa Florida 33603
Clayton Eye Clinical Research, LLC Morrow Georgia 30260
Durrie Vision Overland Park Kansas 66210
Eye Care Institute/Butchertown Clinical Trials Louisville Kentucky 40206
Maine Eye Center Portland Maine 04101
Fraser Eye Care Center Fraser Michigan 48026
Silverstein Eye Centers Kansas City Missouri 64133
Tekwani Vision Center St Louis Missouri 63128
Ophthalmology Associates St Louis Missouri 63131
Ophthalmology Consultantants, Ltd. St Louis Missouri 63131
Comprehensive Eye Care, Ltd. Washington Missouri 63090
Vance Thompson Vision-MT Bozeman Montana 59718
Vance Thompson Vision- NE Omaha Nebraska 68137
Wellish Vision Institute Las Vegas Nevada 89119
Center for Sight Las Vegas Nevada 89145
NYU Grossman School of Medicine New York New York 10017
Seeta Eye Center Poughkeepsie New York 12603
Vance Thompson Vision ND West Fargo North Dakota 58078
Cincinnati Eye Institute Cincinnati Ohio 45242
Cincinnati Eye Institute Mason Ohio 45040
Eye Care Specialists Kingston Pennsylvania 18704
Vance Thompson Vision Sioux Falls South Dakota 57108
Keystone Research Austin Texas 78751
Hill Country Eye Center Cedar Park Texas 78613
Louis M. Alpern, M.D., M.P.H.,P.A. El Paso Texas 79902
Houston Eye Associates Houston Texas 77008
Lake Travis Eye & Laser Center Lakeway Texas 78738
DCT-Shah Research, LLC dba Discovery Clinical Trials Mission Texas 78572
Terry Eye Associates San Antonio Texas 78212

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05528172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 23, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05528172 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →